Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CURI vs GAIA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CURI Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

CURI Overall Winner 6-Pillar Tally: CURI 5 – 1 GAIA Matrix Metrics: CURI 9 – 1 GAIA

As of Nov 20, 2026, CuriosityStream Inc. (CURI) is the stronger overall head-to-head candidate over Gaia, Inc. (GAIA) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CURI carries a Unified Composite Score of 52.8/100 (HOLD) at $2.54 (6.9x Forward P/E, 10.1% operating margin), whereas GAIA carries 48.5/100 (HOLD) at $1.22 (138.9x Forward P/E, -8.7% operating margin).

  • Technical & Structure Timing Caution: CURI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 43.5); meanwhile GAIA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CURI vs GAIA
CURI NASDAQ Head-to-Head Winner
CuriosityStream Inc. Class A Common Stock
Services-Motion Picture & Video Tape Production
$2.54
-2.68% 1D
Market Cap $154.9M
TTM Revenue $78M
Forward P/E 6.9x
Beta / 30D Vol 1.36β · 99% Vol
Unified Composite Score
52.8 / 100 HOLD
Tech 62.0 Fund 53.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.9%), weak momentum, RSI 43
RSI-14: 43.5 · SMA20: $2.67 · SMA50: $2.78
GAIA NASDAQ
Gaia, Inc. Class A Common Stock
Services-Motion Picture & Video Tape Production
$1.22
-3.94% 1D
Market Cap $32.3M
TTM Revenue $95M
Forward P/E 138.9x
Beta / 30D Vol 0.50β · 66% Vol
Unified Composite Score
48.5 / 100 HOLD
Tech 63.0 Fund 73.0 Flow 64.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 40
RSI-14: 39.8 · SMA20: $1.31 · SMA50: $1.33

6-Pillar Scorecard Institutional Category Breakdown (CURI 5 – 1 GAIA)

Columns: Metric · CURI · GAIA
1. Valuation Multiples CURI
Forward P/E 6.9x 138.9x
Trailing P/E 17.4x 138.9x
PEG Ratio N/M 1.23x
EV / Revenue N/M 0.4x
2. Growth & Scale CURI
Revenue Growth (YoY) +12.9% -11.8%
Earnings Growth (YoY) N/A -87.8%
TTM Revenue (USD) $78M $95M
Market Cap $154.9M $32.3M
3. Profitability & Quality CURI
Gross Margin 60.2% 86.1%
Operating Margin 10.1% -8.7%
Net Profit Margin 11.0% -8.2%
Return on Equity (ROE) 19.3% -8.7%
4. Balance Sheet & Cash Flow CURI
Cash Generation (TTM) $25M EBITDA -$776,000
Cash Flow Margin 31.9% EBITDA Mgn -0.8%
Net Cash / Leverage $631M Net Cash $1.5M Net Debt (0.17x D/E)
Dividend Yield 12.02% None (0.00%)
5. Options & Positioning GAIA
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 67.6% (3rd %ile) 146.8% (100th %ile)
Put/Call OI Skew 0.93x (Balanced) N/A
OBV Trend / Tech Phase ACCUMULATION · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CURI
OpEx & R&D Intensity 50.1% of Rev ($39M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Broadcasting Operator Entertainment Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CURI (9) vs GAIA (1)
Institutional Metric CURI GAIA Criterion Row Edge
Market Capitalization
Scale
$154.9M $32.3M Larger Scale CURI
Trailing P/E Ratio
Valuation
17.4x 138.9x Lower Multiple CURI
Forward P/E Ratio
Valuation
6.9x 138.9x Lower Multiple CURI
Revenue Growth (YoY)
Growth
+12.9% -11.8% Higher Growth CURI
Operating Margin (TTM)
Profitability
10.1% -8.7% Higher Margin CURI
Net Profit Margin
Profitability
11.0% -8.2% Higher Margin CURI
Return on Equity (ROE)
Capital Efficiency
19.3% -8.7% Higher ROE CURI
52-Week Range Position
Momentum
9% ($2–$5) 2% ($1–$4) Stronger Trend CURI
Beta / 30D Volatility
Risk Regime
1.36β · 99% Vol 0.50β · 66% Vol Lower Realized Risk GAIA
Unified Institutional Score
Composite Signal
52.8 / 100 (HOLD) 48.5 / 100 (HOLD) Higher Composite CURI
Trailing 12M Revenue (USD)
Operating Scale
$78M $95M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
60.2% 86.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 1.23x PEG · 0.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$25M EBITDA ($631M Net Cash) -$776,000 ($1.5M Net Debt (0.17x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CURI +2.27 pp
CURI: -11.81% · GAIA: -14.08%
3M Horizon CURI +6.45 pp
CURI: -10.56% · GAIA: -17.01%
6M Horizon CURI +50.61 pp
CURI: -0.39% · GAIA: -51.0%
1Y Horizon CURI +24.81 pp
CURI: -44.54% · GAIA: -69.35%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CURI Revenue GAIA Revenue CURI Op. Margin GAIA Op. Margin Margin Leader
FY2018 N/A $40M N/A -86.7% GAIA
FY2019 $20M $50M -247.4% -31.9% GAIA
FY2020 $40M $70M -97.9% -6.9% GAIA
FY2021 $70M $80M -73.6% 2.5% GAIA
FY2022 $80M $80M -70.8% -0.3% GAIA
FY2023 $60M $80M -78.2% -5.7% GAIA
FY2024 $50M $90M -26.1% -6.4% GAIA
FY2025 $70M $100M -10.2% -5.2% GAIA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CURI BREAKDOWN
70d in phase · OBV ACCUMULATION
Current IV 67.6%
IV Percentile 3rd %ile
Put/Call OI Skew 0.93x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CURI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GAIA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 146.8%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GAIA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CURI Moat Profile Scale & Operating Efficiency Moat
Broadcasting Operator
Competes within the Broadcasting value chain with $154.9M market capitalization and 10.1% operating margin.
OpEx & R&D Reinvestment 50.1% of Rev ($39M)
90D Engineering Disclosures 0 Published
GAIA Moat Profile Cyclical / Execution-Driven Positioning
Entertainment Operator
Competes within the Entertainment value chain with $32.3M market capitalization and -8.7% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CURI vs GAIA Key Questions & Quantitative Answers

As of Nov 20, 2026, CuriosityStream Inc. (CURI) is the stronger overall head-to-head candidate over Gaia, Inc. (GAIA) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CURI carries a Unified Composite Score of 52.8/100 (HOLD) at $2.54 (6.9x Forward P/E, 10.1% operating margin), whereas GAIA carries 48.5/100 (HOLD) at $1.22 (138.9x Forward P/E, -8.7% operating margin). Technical & Structure Timing Caution: CURI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 43.5); meanwhile GAIA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CURI leads the Growth & Scale pillar: CURI posts +12.9% YoY revenue growth and N/A YoY earnings growth on $78M TTM revenue (60.2% gross margin, 10.1% operating margin), compared with GAIA at -11.8% YoY revenue growth and -87.8% YoY earnings growth on $95M TTM revenue (86.1% gross margin, -8.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CURI cumulative revenue shifted +250.0% while GAIA shifted +150.0%. In operating R&D and SG&A reinvestment, CURI deploys 50.1% of Rev ($39M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GAIA.

CURI screens cheaper on headline valuation multiples. CURI trades at 6.9x Forward P/E, 17.4x Trailing P/E, N/M PEG, and N/M EV/Revenue (31.9% EBITDA margin), whereas GAIA trades at 138.9x Forward P/E, 138.9x Trailing P/E, 1.23x PEG, and 0.4x EV/Revenue (-0.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CURI (19.3% ROE) versus GAIA (-8.7% ROE) capital efficiency.

In options market volatility and institutional positioning, CURI carries 67.6% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.93x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.36β · 99% Vol realized risk). By comparison, GAIA carries 146.8% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 66% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.